Delivery Order SPE2DB24D2205-SPE2DB25FEFKF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,010.94 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine HCL 4% Solution in 4ML vials, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency Troop Support Medical awarded a $2,399.04 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milliliters of 2% viscous lidocaine solution. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a single day's supply to fulfill an immediate need, with performance required between August 1st and 2nd, 2023. As a major medical distributor, Amerisourcebergen routinely supports the Defense...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania. The $1,623.22 order is for the supply of Lidocaine HCL 4% Solution in 4 mL vials. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency awarded a $516 firm fixed price delivery order to Amerisourcebergen Drug Corporation for lidocaine hydrochloride 1% 50 mg/5 ml vials. The order is for five milliliter vials of the topical anesthetic to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen routinely supports the Defense Logistics Agency's stockpile of medical materiel through...
- The Defense Logistics Agency Troop Support Medical awarded a $173,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for lidocaine hydrochloride. The one-day contract has a period of performance from July 20, 2023 through July 21, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation, use of subcontractors, or designation of any set-asides. The...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,114.40 firm fixed-price delivery order is for the procurement of 4566619544 - Lidocaine HCL 5ML 25S medical supplies. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not designated with any set-aside...
- This is a $1,366.67 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% Vial 50ML, a pharmaceutical product, with a period of performance through June 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $358 delivery order to Amerisourcebergen Drug Corporation for lidocaine hydrochloride injection 1% vials. The firm fixed price order is for 10mL vials of the injectable anesthetic to be delivered to a facility in Conshohocken, Pennsylvania between July 24-25, 2023. Amerisourcebergen will fulfill the order as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military services and combatant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,731.76 firm-fixed-price delivery order is for the supply of 4560703404 - Lidocaine HCL 1% Vial 2ML, with a period of performance through April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at approximately $891 to Amerisourcebergen Drug Corporation for the supply of lidocaine hydrochloride injection, 1% vial, 10mL. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide pharmaceutical products to DLA and DoD customers through August 18, 2023. Performance will occur at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, which supports various...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFKFDelivery Order
The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio of federal medical procurement awards demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains. This delivery order exemplifies the ongoing operational demand for essential medical commodities within the Defense Health Agency supply chain, with the firm fixed-price structure providing budget certainty for this medical procurement requirement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/25/25 |